Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility

Front Immunol. 2019 Aug 27:10:2032. doi: 10.3389/fimmu.2019.02032. eCollection 2019.

Authors

An M T Van Nuffel¹, Caroline Boudousquié², Sandra Tuyaerts^{3

4}

Affiliations

¹ The Anticancer Fund, Brussels, Belgium.
² Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
³ Division of Gynecologic Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
⁴ Leuven Cancer Institute (LKI), Leuven, Belgium.

No abstract available

Keywords: adjuvant; antigen-presenting cell; biomarkers; cancer vaccines; immunosuppression; in situ vaccination; personalized.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Adjuvants, Immunologic
Antigen-Presenting Cells / immunology
Antigens, Neoplasm / immunology
Cancer Vaccines / immunology*
Cancer Vaccines / therapeutic use*
Humans
Lymphocytes / immunology
Lymphocytes / metabolism
Neoplasms / immunology*
Neoplasms / therapy*

Substances

Adjuvants, Immunologic
Antigens, Neoplasm
Cancer Vaccines